<DOC>
	<DOCNO>NCT01689831</DOCNO>
	<brief_summary>Dose comparison study tuberculin purified protein derivative ( PPD ) Aplisol standard tuberculin purify derivative ( PPD-S2 ) .</brief_summary>
	<brief_title>Dose Study Tuberculin Purified Protein Derivative ( JHP/Dose )</brief_title>
	<detailed_description>JHP propose demonstrate clinical comparability Aplisol formulate new Tuberculin PPD drug substance standard PPD-S2 .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>1 . Males nonpregnant female age 18 60 year 2 . Documented PPD reactivity 5 21 mm past , document medical record . Selfreported PPD reactivity accept medical record obtain . 3 . Give write informed consent participate 4 . Generally healthy , determined medical history target physical examination , indicate 5 . Possess 2 forearm free burn , scar , eczema , physical deformity , could impair injection study preparation reading injection 6 . Comprehension study requirement ; express availability require study period , include reading nominal time point 48 72 hour 1 . Prior PPD test within past 30 day 2 . Subject childbearing potential unable use contraceptive ; plan pregnancy ; pregnant lactate 3 . History anaphylactic reaction , severe positive tuberculin reaction ( eg , ulceration , necrosis ) severe reaction PPD past 4 . Subject receive Bacillus CalmetteGu√©rin ( BCG ) vaccination past , born live outside US child uncertain his/her BCG vaccination status 5 . Presence condition may suppress TST reactivity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>